Form 144: Proposed sales of 50,000 Common shares reported

The issuer disclosed proposed sales of Common shares via Form 144, reporting multiple 10b5-1 plan transactions by related trusts.

Rhea-AI Filing Summary

The issuer disclosed proposed sales of Common shares via Form 144, reporting multiple 10b5-1 plan transactions by related trusts. The filing lists a Founders Shares block of 50,000 shares and multiple executed plan sales dated between 04/21/2026 and 06/10/2026, with per‑trade share counts and gross proceeds shown for each trade.

Insights

Compliance / Insider Transactions Analyst

Multiple planned sales under 10b5-1 by trusts are reported with per-trade quantities and proceeds.

The excerpt lists routine Rule 144/Form 144 disclosures for proposed or reported dispositions of Common stock, including a Founders Shares entry of 50,000 shares. Several entries are labeled as 10b5-1 Sales with explicit trade dates, share counts, and gross amounts.

These items are procedural notices of sale activity by identified trusts; the filings show per-trade details (dates, shares, proceeds) rather than a single aggregated offering. Subsequent public filings would show whether additional transactions or post-trade holdings change the position picture.

Key Figures

Founders Shares: 50,000 shares Trade example: 100,000 shares Trade example: 50,000 shares +2 more

5 metrics

Founders Shares 50,000 shares listed as Founders Shares (06/06/2012)

Trade example 100,000 shares 10b5-1 sale on <date>05/11/2026</date> with <money>$8,403,600.00</money>

Trade example 50,000 shares 10b5-1 sale on <date>05/11/2026</date> with <money>$4,391,065.00</money>

Trade example 10,280 shares 10b5-1 sale on <date>06/02/2026</date> with <money>$877,115.30</money>

Trade example 100 shares 10b5-1 sale on <date>06/10/2026</date> with <money>$7,000.00</money>

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"Entries labeled "10b5-1 Sales" listing trusts and trade details"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Header and context indicating proposed sales under Rule 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares market

"Line showing "Founders Shares" with a 50,000 share entry dated 06/06/2012"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for P disclose?

The Form 144 lists proposed or reported dispositions of Common stock, including a Founders Shares block of 50,000 shares and multiple 10b5-1 plan sales dated 04/21/2026 through 06/10/2026 with per-trade proceeds shown.

Which trades are shown in the excerpt?

The excerpt shows multiple trust trades under 10b5-1 plans, for example 100,000 shares on 05/11/2026 with $8,403,600.00 gross and 50,000 shares on 05/11/2026 with $4,391,065.00 gross.

Are the sales tied to prearranged 10b5-1 plans?

Yes. The transactions are labeled as 10b5-1 Sales for named trusts (e.g., THE EEC TRUST, THE RWC TRUST), indicating sales executed under prearranged plans as reported in the excerpt.

Does the filing state who receives the proceeds?

The excerpt lists gross proceeds per trade (e.g., $4,391,065.00), but it does not reallocate proceeds among parties; the entries identify the selling trusts as the counterparties for each reported sale.

What date range do the reported trades cover?

Reported trade dates in the excerpt span from 04/21/2026 through 06/10/2026, with multiple transactions recorded on 04/21/2026, 04/22/2026, 04/23/2026, 04/24/2026, 05/05/2026, 05/06/2026, 05/07/2026, 05/11/2026, 06/02/2026, and 06/10/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:43 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001651902
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Everpure, Inc.
SEC File Number	001-37570
Address of Issuer	2555 Augustine Dr. Santa Clara CALIFORNIA 95054
Phone	8003797873
Name of Person for Whose Account the Securities are To Be Sold	THE EEC TRUST U/A DTD 02/08/2011
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	3467000.00	332404932	06/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/06/2012	Founders Shares	Issuer			50000	06/06/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	06/10/2026	100	7000.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	06/02/2026	10280	877115.30
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	05/11/2026	50000	4391065.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	05/11/2026	100000	8403600.00
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	05/11/2026	50000	4391065.00
10b5-1 Sales for COLGROVE FAM LIVING TR DTD 7/12/99 2555 Augustine Dr. Santa Clara CA 95054	Common	05/07/2026	29108	2192120.57
10b5-1 Sales for COLGROVE FAM LIVING TR DTD 7/12/99 2555 Augustine Dr. Santa Clara CA 95054	Common	05/06/2026	27578	2068551.32
10b5-1 Sales for COLGROVE FAM LIVING TR DTD 7/12/99 2555 Augustine Dr. Santa Clara CA 95054	Common	05/05/2026	77579	5827400.89
10b5-1 Sales for VCF TRUST U/A DTD 12/05/2025 2555 Augustine Dr. Santa Clara CA 95054	Common	04/24/2026	28935	2025881.13
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	04/23/2026	16876	1182712.27
10b5-1 Sales for VCF TRUST U/A DTD 12/05/2025 2555 Augustine Dr. Santa Clara CA 95054	Common	04/23/2026	37992	2660851.80
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	04/23/2026	17091	1197728.73
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	04/22/2026	27457	1935811.85
10b5-1 Sales for VCF TRUST U/A DTD 12/05/2025 2555 Augustine Dr. Santa Clara CA 95054	Common	04/22/2026	27464	1936220.24
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	04/22/2026	27345	1927967.43
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	04/21/2026	5667	397037.39
10b5-1 Sales for VCF TRUST U/A DTD 12/05/2025 2555 Augustine Dr. Santa Clara CA 95054	Common	04/21/2026	5609	392988.98
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	04/21/2026	5564	389829.98

144: Remarks and Signature

Remarks
Date of Notice	06/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph T Fitzgerald TTEE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)